Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

The Myeloma Center at New York Presbyterian – Weill Cornell Medical Center is a comprehensive program for the treatment of multiple myeloma and related plasma cell diseases. Our focus is on providing cutting edge medical technologies and the latest in myeloma treatment personalized to each patient.


July 28, 2020
CAR T-Cell Therapy for Treatment of Myeloma
Chimeric antigen receptor (CAR) T-cell therapy is a novel form of immunotherapy that leverages the strength of a patient’s own immune system to fight myeloma.Immune cells called T...
April 1, 2019
Multi-Color Capsule
Despite advancements in myeloma treatment, patients often experience disease recurrence and progression that necessitates successive therapeutic intervention. With exposure to...
March 20, 2019
Physical activity offers a host of bodily benefits, including but not limited to increased strength and ease of movement, and improved efficiency of the heart and lungs. It can...

In May 2018, the Myeloma Center moved to 425 E. 61st St – 8th Floor. Learn more about this location.

For Patients

Make an appointment, prepare for your first visit, and access our health information library, complete with resources on frequently asked questions, our ongoing support groups and the latest research and treatments.

Find out more about patient care

Research and Clinical Trials

Research and clinical trials are critical to developing new treatments and cures for myeloma, amyloidosis and related plasma cell disorders. Learn about our world-class research program which offers Myeloma Center patients access to the newest therapies.

Find out more about research

Our Team

Meet our healthcare team and learn about our approach to care. We have many years of expertise in providing outstanding clinical care in the treatment of multiple myeloma, amyloidosis and other plasma cell disorders.

View All Team Members